Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 1

2(40.0%)

5Total

N/A(3)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT05919940Not ApplicableRecruiting

Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO )

Role: collaborator

NCT07153289Phase 1Not Yet Recruiting

CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)

Role: collaborator

NCT05818449Not ApplicableActive Not Recruiting

Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)

Role: collaborator

NCT04384198Not ApplicableUnknown

TransCranial Doppler for REDUCtion of Silent strokE During MitraClip Implantation

Role: collaborator

NCT04711486Phase 1Completed

Evaluation of Safety of Contraloid Acetate in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

Role: collaborator

NCT04320667Unknown

Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis

Role: collaborator

NCT04320797Unknown

Urinary T Cell Biomarker for Prediction in Lupus Nephritis

Role: collaborator

NCT01277419Recruiting

German Spondyloarthritis Inception Cohort

Role: collaborator

NCT04747366Unknown

Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity

Role: collaborator

NCT02530229Unknown

Arthrocentesis Study

Role: collaborator

All 10 trials loaded